AMCo comes again for a bolt-on levloan

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

AMCo comes again for a bolt-on levloan

Pills_230px

Amdipharm Mercury, the UK generic pharmaceuticals company also known as AMCo, has laid out price guidance for a €163.7m leveraged loan that will fund a bolt-on acquisition.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article